Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Atypical Pneumonia

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An 18-hour concentration test of kidney function.

The American journal of the medical sciences·2010

Same author

DIET AND NUTRITION: NORMAL NUTRITION.

Canadian Medical Association journal·2010

Same author

A convertible kymograph with synchronous motor, and a timing pendulum for universal driving current.

Federation proceedings·2010

Same author

Renal tubule work; its significance for the clinician.

University Hospital bulletin·2010

Same author

I. On the Cause of the Heart Beat.

Journal. Boston Society of Medical Sciences·2009

Same author

On Methods of isolating the Mammalian Heart.

Journal. Boston Society of Medical Sciences·2009

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

THE HEART MUSCLE IN PNEUMONIA.

L H Newburgh¹, W T Porter

¹Laboratory of Comparative Physiology and the Department of Medicine of the Harvard Medical School, Boston.

The Journal of Experimental Medicine

|October 30, 2009

Summary

This summary is machine-generated.

Heart muscle function is preserved in pneumonia, but direct exposure to pneumonic blood impairs cardiac efficiency. The heart can adapt to gradual exposure to toxins associated with pneumonia.

More Related Videos

Microdissection and Immunofluorescence Staining of Myocardial Sleeves in Murine Pulmonary Veins

Microdissection and Immunofluorescence Staining of Myocardial Sleeves in Murine Pulmonary Veins

Published on: November 21, 2023

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Published on: May 13, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Microdissection and Immunofluorescence Staining of Myocardial Sleeves in Murine Pulmonary Veins

Microdissection and Immunofluorescence Staining of Myocardial Sleeves in Murine Pulmonary Veins

Published on: November 21, 2023

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

Published on: May 13, 2019

Area of Science:

Cardiology
Pulmonary Medicine
Pathophysiology

Background:

Pneumonia can affect systemic functions beyond the lungs.
The impact of pneumonia on cardiac muscle contractility requires further elucidation.

Purpose of the Study:

To investigate the functional status of heart muscle during pneumonia.
To determine the effects of pneumonic blood on normal cardiac muscle.
To assess the adaptive capacity of heart muscle to pneumonic toxins.

Main Methods:

Assessing ventricular function in the context of pneumonia.
Introducing pneumonic blood to normal cardiac tissue to observe functional changes.
Evaluating cardiac muscle response to gradual exposure to pneumonia-related toxins.

Main Results:

Heart muscle in pneumonia demonstrates normal function when supplied with normal blood.
Sudden exposure of normal heart muscle to pneumonic blood significantly reduces cardiac efficiency, contractility duration, and area.
Gradual exposure to pneumonia-associated toxins allows the heart muscle to adapt and partially adjust its function.

Conclusions:

Cardiac muscle retains functional integrity during pneumonia if adequately supplied.
Pneumonic blood poses an acute risk to cardiac function, impairing contractility.
The heart exhibits a degree of plasticity, adapting to sustained exposure to pneumonia-induced cardiac stressors.